DocTrials

A clinical research study is looking at an experimental drug for diabetic retinopathy. Are you interested? Call now. 480-999-5458

Can you believe it’s already August? We’re excited to announce our upcoming studies this month at our Arizona locations: retinal vein occlusion, uveitic macular edema, macular degeneration, and dry eyes. If you or someone you know might benefit, give us a call at 480-999-5458. To see a list of our currently enrolling studies visit us at DocTrials.com or click on the enrolling studies page linked in our bio.

Diabetic peripheral neuropathic pain (DPNP) affects many people with diabetes. The PROGRESS study is currently exploring the effectiveness of an investigational drug called LX9211 to help treat this condition. LX9211 is a new type of investigational drug called an AP2-associated protein kinase 1 inhibitor (AAK1 inhibitor). It is believed that inhibiting AAK1 may help reduce pain caused by diabetic neuropathy.

Learn more about the study or if you may qualify: Call our Research Team at 480-999-5458, or visit our enrolling studies page linked in our bio. Location: Integrated Pain Consultants in Scottsdale, AZ

DocTrials Bringing clinical research opportunities to patients and doctors in the communities we work in. Located in Arizona, California, and Nevada

We’re searching for adults aged over 18 who have diabetic retinopathy to take part in a clinical research study.

Contact us.

It takes intense research to fight diabetic peripheral neuropathic pain.
Join a clinical study testing an investigational drug for pain related to DPN.

The PROGRESS study is being done to find out the efficacy of an investigational drug called LX9211 in reducing pain related to diabetic peripheral neuropathy.

LX9211 is a new type of investigational drug called an AP2-associated protein kinase 1 inhibitor (AAK1 inhibitor). It is believed that inhibiting AAK1 may help reduce pain caused by diabetic neuropathy.

You may qualify to participate if you:
o Are 18 years of age or older
o Have type 1 or type 2 diabetes
o Have an A1C less than or equal to 11%
o Have ongoing diabetic peripheral neuropathy with moderate to severe pain

Your medical history and other criteria will be checked to see if you can take part in the study.

The study lasts about 16 weeks. Qualified participants will not have to pay for the study drug, study visits, or for the procedures or tests that are needed as part of this study. Additionally, you may be compensated for your time and reimbursed for approved, study-related travel.

Learn more:
Integrated Pain Consultants (Scottsdale, AZ)
Call our Research Team: 480-999-5458
or apply online: https://www.doctrials.com/pain-studies #!/study/404

Are you aged 18 to 85 and looking for a possible treatment for your diabetic macular edema (DME)? If so, consider taking part in the DIAMOND-2 Study of an investigational eye drop called OCS-01. To learn more about this clinical research study, please call 480-999-5458 or apply online by clicking the link in our bio.

Learn more about the PROGRESS study for adults who have diabetic peripheral neuropathic pain (DPNP) with moderate to severe pain. Learn more: 480-999-5458, email [email protected], or apply online by visiting our enrolling studies page linked in our bio.

LX9211 is a new type of investigational drug being explored for the potential treatment of diabetic peripheral neuropathic pain (DPNP). It is a type of drug called an AP2-associated protein kinase 1 inhibitor (AAK1 inhibitor). It is believed that inhibiting AAK1 may help reduce pain caused by diabetic neuropathy.

The PROGRESS study is currently seeking people with DPNP to participate. The study lasts about 16 weeks, and all study procedures are provided at no cost. Learn more about the study or if you may qualify: 480-999-5458 or apply online at https://www.doctrials.com/integrated-pain-consultants-doctrials #!/study/404

Our retina research team received a heartwarming surprise— a delightful gift of coffee from Guatemala! The thoughtful note that came with it truly made our day. 🧡 A big shoutout to our dedicated retina research team for their hard work and commitment to excellence!

Balancing work, wellness, and education is key to our success and last week we hiked Camelback Mountain for a stunning sunrise and later attended the Society of Clinical Research West Summit. It was a valuable experience, offering insights into new technology and gave us the chance to connect with other professionals in our field. We’re pumped to apply what we learned!

Celebrating National Golf Day by swinging down memory lane to our fantastic company golf par-tee! 🏌️‍♂️⛳️ Drop by our page to learn more about our incredible team and discover the exciting eye and pain studies we’re currently enrolling in.

Diabetic Macular Edema: Now enrolling at Associated Retina Consultants in Phoenix, AZ. Apply online at www.doctrials.com or call 480-999-5458.

Geographic Study (GA): Now enrolling at Associated Retina Consultants in Phoenix and Gilbert, AZ. Apply online at www.doctrials.com or call 480-999-5458.

Diabetic Neuropathy Study: Now enrolling at Integrated Pain Consultants in Scottsdale, AZ. Apply online at www.doctrials.com or call 480-999-5458.

If you have diabetic macular edema (DME), the DIAMOND-2 Study may be right for you. We are enrolling adults in this study of an investigational eye drop called OCS-01 to further evaluate its efficacy and safety profile in the treatment of DME. For more information, please call 480-999-5458.

The LUNA Study is recruiting now!

We’re testing a study treatment to see if it could help people aged 50 or over with wet AMD.

Learn more on our website.

480-999-5458
https://www.doctrials.com/enrolling-studies-form #!/study/316

🕶️🌞 Shield Your Eyes, Protect Your Sight! 🌞🕶️

👀 Did you know? Excess sun exposure isn't just harmful to your skin, but it could also put your precious eyes at risk! From growths in or on the eye to cataracts, sunburned eyes, and even cancer, the dangers of UV rays are real.

🔍 To see if we have any ongoing clinical trials for eye conditions thought to be related to long-term exposure to the sun's ultraviolet (UV) light, visit us at doctrials.com/enrollingstudies or call 480-999-5458.

DocTrials is looking for volunteers who are in good general health to participate in a clinical research study evaluating an investigational eye drop. Call or apply online today to see if you qualify. Study being conducted in Chandler, AZ.
https://www.doctrials.com/enrolling-studies-form #!/study/373

Happy Employee Appreciation Day!
We want to thank all our wonderful employees to let you know how special you are to us!

DocTrials has the best team around…we’re not biased either, it’s been proven day after day!

We have teams all over the valley-Chandler, Sun City, 3 sites in Phoenix and soon-to-be Gilbert. We also have teams in Santa Barbara, California and Henderson, Nevada!

If you want to join in on the fun contact us at DocTrials.com

The Esther study is recruiting people with glaucoma and ocular hypertension to compare preservative-free glaucoma treatment against standard of care.

Happy New Years! Looking forward to a great 2023!
See how you can be involved in a clinical trial. Call 480-999-5458 for more information.

Or visit our website at doctrials.com.

(presbyopia)

See how you can be involved in a clinical trial. Call 480-999-5458 for more information.

Sweet gift from our sweet patient!

Take time to reflect. Happy Thanksgiving. ~DocTrials

November is National Diabetes Month. Protect your vision from diabetes. Have a dilated eye exam every year, and follow these steps to keep your health on TRACK.

T = Take your medications as prescribed by your doctor.
R = Reach and maintain a healthy weight.
A = Add more physical activity to your daily routine.
C = Control your ABC's- A1C, blood pressure, and cholesterol levels.
K = Kick the smoking habit.


www.nei.nih.gov/diabetes

Apply online to see if you qualify for a diabetic-related eye study:
doctrials.com/enrollingstudies
480-999-5458

Today marks World Sight Day and we are focusing the world’s attention on the importance of eye care. Join us to help people prioritize their own eye health and leaders to ensure eye care is accessible, inclusive and affordable to everyone, everywhere.⁠
This is a reminder to schedule a checkup with your eye doctor today. ⁠⁠
⁠⁠⁠⁠
Or visit our website at doctrials.com.⁠⁠⁠
(presbyopia)

Today marks World Sight Day and we are focusing the world’s attention on the importance of eye care.​ Join us to help people prioritize their own eye health and leaders to ensure eye care is accessible, inclusive and affordable to everyone, everywhere.​
This is a reminder to schedule a checkup with your doctor today.

Or visit our website at doctrials.com.
(presbyopia)

🧡 Perfecting best practices in clinical research at the Global Site Solutions Summit in Miami thanks to the Society for Clinical Research Sites

We are looking SPEC-tacular! What do you think?

Who is ready for Fall?
See how you can be involved in a clinical trial. Call 480-999-5458 for more information.

Or visit our website at doctrials.com.

(presbyopia)

Presbyopia Research Opportunity.
You may be eligible for a research study for adults with Presbyopia. Get more information about this study evaluating an investigational treatment.

Join a research study on Presbyopia near you.

Locations at our Arizona Eye Center and Walman Eye Center.
Call us at 480-999-5458 for more details, or visit our website at doctrials.com.


See how you can be involved in a clinical trial. Call 480-999-5458 for more information.

Or visit our website at doctrials.com.